https://stock.noler.com/us/stock/aptalis-pharma-inc https://stock.noler.com/us/stock/aptalis-pharma-inc/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/aptalis-pharma-inc/accounts-receivable https://stock.noler.com/us/stock/aptalis-pharma-inc/accrued-income-taxes-current https://stock.noler.com/us/stock/aptalis-pharma-inc/accumulated-amortization-of-noncurrent-deferred-finance-costs https://stock.noler.com/us/stock/aptalis-pharma-inc/acquisitions https://stock.noler.com/us/stock/aptalis-pharma-inc/additional-paid-in-capital https://stock.noler.com/us/stock/aptalis-pharma-inc/aoci https://stock.noler.com/us/stock/aptalis-pharma-inc/capital-expenditures https://stock.noler.com/us/stock/aptalis-pharma-inc/cash-and-equivalents https://stock.noler.com/us/stock/aptalis-pharma-inc/cash-flow-breakdown https://stock.noler.com/us/stock/aptalis-pharma-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/aptalis-pharma-inc/common-stock-value https://stock.noler.com/us/stock/aptalis-pharma-inc/comprehensive-income https://stock.noler.com/us/stock/aptalis-pharma-inc/cost-of-goods-sold-excluding-depreciation-depletion-and-amortization https://stock.noler.com/us/stock/aptalis-pharma-inc/costs-and-expenses https://stock.noler.com/us/stock/aptalis-pharma-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/aptalis-pharma-inc/current-assets https://stock.noler.com/us/stock/aptalis-pharma-inc/current-liabilities https://stock.noler.com/us/stock/aptalis-pharma-inc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/aptalis-pharma-inc/debt-issued https://stock.noler.com/us/stock/aptalis-pharma-inc/debt-repaid https://stock.noler.com/us/stock/aptalis-pharma-inc/deferred-finance-costs-noncurrent-net https://stock.noler.com/us/stock/aptalis-pharma-inc/deferred-income-taxes-and-tax-credits https://stock.noler.com/us/stock/aptalis-pharma-inc/deferred-tax-assets-net-current https://stock.noler.com/us/stock/aptalis-pharma-inc/deferred-tax-assets-net-noncurrent https://stock.noler.com/us/stock/aptalis-pharma-inc/deferred-tax-liabilities-current https://stock.noler.com/us/stock/aptalis-pharma-inc/deferred-tax-liabilities-noncurrent https://stock.noler.com/us/stock/aptalis-pharma-inc/depreciation-and-amortization https://stock.noler.com/us/stock/aptalis-pharma-inc/dividends-common-stock-cash https://stock.noler.com/us/stock/aptalis-pharma-inc/dividends-paid https://stock.noler.com/us/stock/aptalis-pharma-inc/due-from-related-parties-current https://stock.noler.com/us/stock/aptalis-pharma-inc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/aptalis-pharma-inc/financing-cash-flow https://stock.noler.com/us/stock/aptalis-pharma-inc/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/aptalis-pharma-inc/foreign-currency-transaction-gain-loss-unrealized https://stock.noler.com/us/stock/aptalis-pharma-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/aptalis-pharma-inc/goodwill https://stock.noler.com/us/stock/aptalis-pharma-inc/goodwill-and-intangible-asset-impairment https://stock.noler.com/us/stock/aptalis-pharma-inc/income-tax https://stock.noler.com/us/stock/aptalis-pharma-inc/income-taxes-receivable https://stock.noler.com/us/stock/aptalis-pharma-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/aptalis-pharma-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/aptalis-pharma-inc/increase-decrease-in-accrued-income-taxes-payable https://stock.noler.com/us/stock/aptalis-pharma-inc/increase-decrease-in-due-from-related-parties-current https://stock.noler.com/us/stock/aptalis-pharma-inc/increase-decrease-in-income-taxes-receivable https://stock.noler.com/us/stock/aptalis-pharma-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/aptalis-pharma-inc/increase-decrease-in-other-noncurrent-liabilities https://stock.noler.com/us/stock/aptalis-pharma-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/aptalis-pharma-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/aptalis-pharma-inc/interest-and-debt-expense https://stock.noler.com/us/stock/aptalis-pharma-inc/inventory https://stock.noler.com/us/stock/aptalis-pharma-inc/investing-cash-flow https://stock.noler.com/us/stock/aptalis-pharma-inc/investment-income-interest https://stock.noler.com/us/stock/aptalis-pharma-inc/long-term-debt https://stock.noler.com/us/stock/aptalis-pharma-inc/net-change-in-cash https://stock.noler.com/us/stock/aptalis-pharma-inc/net-income https://stock.noler.com/us/stock/aptalis-pharma-inc/oci-derivatives-qualifying-as-hedges-net-of-tax-change https://stock.noler.com/us/stock/aptalis-pharma-inc/oci-derivatives-qualifying-as-hedges-tax-effect-change https://stock.noler.com/us/stock/aptalis-pharma-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax-change https://stock.noler.com/us/stock/aptalis-pharma-inc/operating-cash-flow https://stock.noler.com/us/stock/aptalis-pharma-inc/operating-income https://stock.noler.com/us/stock/aptalis-pharma-inc/other-income https://stock.noler.com/us/stock/aptalis-pharma-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/aptalis-pharma-inc/other-nonoperating-income https://stock.noler.com/us/stock/aptalis-pharma-inc/other-sales-revenue-net https://stock.noler.com/us/stock/aptalis-pharma-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/aptalis-pharma-inc/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/aptalis-pharma-inc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/aptalis-pharma-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/aptalis-pharma-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/aptalis-pharma-inc/proceeds-from-contributions-from-parent https://stock.noler.com/us/stock/aptalis-pharma-inc/proceeds-from-sale-of-intangible-assets https://stock.noler.com/us/stock/aptalis-pharma-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/aptalis-pharma-inc/property-plant-equipment https://stock.noler.com/us/stock/aptalis-pharma-inc/public-float https://stock.noler.com/us/stock/aptalis-pharma-inc/receivable-from-shareholders-or-affiliates-for-issuance-of-capital-stock https://stock.noler.com/us/stock/aptalis-pharma-inc/repayment-of-notes-receivable-from-related-parties https://stock.noler.com/us/stock/aptalis-pharma-inc/research-and-development-arrangement-contract-to-perform-for-others-compensation-earned https://stock.noler.com/us/stock/aptalis-pharma-inc/research-and-development-arrangement-contract-to-perform-for-others-costs-incurred-gross https://stock.noler.com/us/stock/aptalis-pharma-inc/research-and-development-asset-acquired-other-than-through-acquisition-written-off https://stock.noler.com/us/stock/aptalis-pharma-inc/research-and-development-expense-excluding-acquired-in-process-cost https://stock.noler.com/us/stock/aptalis-pharma-inc/retained-earnings https://stock.noler.com/us/stock/aptalis-pharma-inc/revenue https://stock.noler.com/us/stock/aptalis-pharma-inc/royalty-revenue https://stock.noler.com/us/stock/aptalis-pharma-inc/sales-revenue-goods-net https://stock.noler.com/us/stock/aptalis-pharma-inc/sga-expense https://stock.noler.com/us/stock/aptalis-pharma-inc/shareholders-equity https://stock.noler.com/us/stock/aptalis-pharma-inc/shares-authorized https://stock.noler.com/us/stock/aptalis-pharma-inc/shares-issued https://stock.noler.com/us/stock/aptalis-pharma-inc/sponsor-fees https://stock.noler.com/us/stock/aptalis-pharma-inc/stock-based-compensation https://stock.noler.com/us/stock/aptalis-pharma-inc/total-assets https://stock.noler.com/us/stock/aptalis-pharma-inc/total-liabilities https://stock.noler.com/us/stock/aptalis-pharma-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/aptalis-pharma-inc/unrealized-gain-loss-on-derivatives